TMC Life Sciences Berhad Statistics

Total Valuation

TMC Life Sciences Berhad has a market cap or net worth of MYR 862.23 million. The enterprise value is 891.55 million.

Market Cap	862.23M
Enterprise Value	891.55M

Important Dates

The next estimated earnings date is Thursday, January 23, 2025.

Earnings Date	Jan 23, 2025
Ex-Dividend Date	Dec 5, 2024

Share Statistics

TMC Life Sciences Berhad has 1.74 billion shares outstanding.

Current Share Class	n/a
Shares Outstanding	1.74B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	11.87%
Owned by Institutions (%)	1.41%
Float	308.63M

Valuation Ratios

The trailing PE ratio is 30.37.

PE Ratio	30.37
Forward PE	n/a
PS Ratio	2.57
PB Ratio	0.97
P/TBV Ratio	1.26
P/FCF Ratio	45.77
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.33, with an EV/FCF ratio of 47.32.

EV / Earnings	31.34
EV / Sales	2.65
EV / EBITDA	13.33
EV / EBIT	21.51
EV / FCF	47.32

Financial Position

The company has a current ratio of 2.77, with a Debt / Equity ratio of 0.23.

Current Ratio	2.77
Quick Ratio	2.64
Debt / Equity	0.23
Debt / EBITDA	3.02
Debt / FCF	10.71
Interest Coverage	4.11

Financial Efficiency

Return on equity (ROE) is 3.22% and return on invested capital (ROIC) is 2.37%.

Return on Equity (ROE)	3.22%
Return on Assets (ROA)	2.19%
Return on Capital (ROIC)	2.37%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.28
Inventory Turnover	16.63

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.79% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-29.79%
50-Day Moving Average	0.52
200-Day Moving Average	0.62
Relative Strength Index (RSI)	30.92
Average Volume (20 Days)	286,050

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TMC Life Sciences Berhad had revenue of MYR 335.95 million and earned 28.44 million in profits. Earnings per share was 0.02.

Revenue	335.95M
Gross Profit	124.44M
Operating Income	41.45M
Pretax Income	36.94M
Net Income	28.44M
EBITDA	64.65M
EBIT	41.45M
Earnings Per Share (EPS)	0.02

Full Income Statement

Balance Sheet

The company has 172.41 million in cash and 201.73 million in debt, giving a net cash position of -29.32 million or -0.02 per share.

Cash & Cash Equivalents	172.41M
Total Debt	201.73M
Net Cash	-29.32M
Net Cash Per Share	-0.02
Equity (Book Value)	890.98M
Book Value Per Share	0.51
Working Capital	160.37M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 52.46 million and capital expenditures -33.62 million, giving a free cash flow of 18.84 million.

Operating Cash Flow	52.46M
Capital Expenditures	-33.62M
Free Cash Flow	18.84M
FCF Per Share	0.01

Full Cash Flow Statement

Margins

Gross margin is 37.04%, with operating and profit margins of 12.34% and 8.47%.

Gross Margin	37.04%
Operating Margin	12.34%
Pretax Margin	10.99%
Profit Margin	8.47%
EBITDA Margin	19.24%
EBIT Margin	12.34%
FCF Margin	5.61%

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 4.48%.

Dividend Per Share	0.02
Dividend Yield	4.48%
Dividend Growth (YoY)	163.93%
Years of Dividend Growth	2
Payout Ratio	51.43%
Buyback Yield	n/a
Shareholder Yield	4.48%
Earnings Yield	3.29%
FCF Yield	2.19%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TMC Life Sciences Berhad has an Altman Z-Score of 3.31.

Altman Z-Score	3.31
Piotroski F-Score	n/a